Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Curis Lifesciences Ltd. Share Price
Day's Range
Day's Range
Low
₹0.00
High
₹0.00
Price Summary
| Previous Close | ₹102.00 |
|---|---|
| Day's Range | ₹0.00 - ₹0.00 |
| Open | ₹0.00 |
| 52 Week Range | ₹83.60 - ₹147.90 |
| Volume | 0 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 11.92 |
| TTM EPS (₹) | 8.56 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 1.74 |
| PAT Margin (%) | 12.43 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 34.25 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | N/A | 502.59 |
| Expenses | N/A | N/A |
| PBT | N/A | 89.88 |
| Operating profit | N/A | 0.0 |
| Net profit | N/A | 62.06 |
About Curis Lifesciences Ltd.
| Founded | 2016 |
|---|---|
| Managing Director | Dharmesh Dasharathbhai Patel |
| NSE Symbol | CURIS |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,66,154.79 | 1,924.90 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 2,25,648.29 | 8,500.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,85,478.78 | 4,840.30 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,23,582.91 | 8,925.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,18,027.35 | 1,450.00 | 1,165.70 - 1,165.70 |
| Zydus Lifesciences Ltd. | 1,17,007.20 | 1,140.00 | 835.50 - 835.50 |
| Lenskart Solutions Ltd. | 1,03,767.01 | 611.40 | 0.00 - 0.00 |
| Lupin Ltd. | 1,03,380.81 | 2,235.00 | 1,875.00 - 1,875.00 |
| Dr. Reddy's Laboratories Ltd. | 1,00,661.90 | 1,202.00 | 1,101.00 - 1,101.00 |
| Mankind Pharma Ltd. | 99,862.43 | 2,420.00 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
KMC Speciality Hospitals (India) informs about outcome of board meeting
Dr. Agarwals Health Care informs about SAST
Dr. Agarwals Health Care informs about SAST updates
Dr. Agarwals Health Care informs about SAST disclosure
Pharmaids Pharmaceuticals informs about newspaper advertisement
Pursuant to Regulation 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Pharmaids Pharmaceuticals has informed that it enclosed copies of the newspaper advertisement pertaining to the unaudited financial results of the company for the quarter ended June 30, 2026. The advertisement was published on Friday, August 14, 2026, in English Newspaper having nationwide circulation 'Financial Express' and Vernacular Newspaper 'Hosa Digantha'. This information will also be made available on the Company’s website at: www.pharmaids.com.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Curis Lifesciences Ltd. is ₹102.00 as of 2026-08-14.
The market capitalisation of Curis Lifesciences Ltd. is ₹82.46 as of 2026-08-13.
The 1-year return of Curis Lifesciences Ltd. is % as of .
The P/E ratio of Curis Lifesciences Ltd. is 0.00 as of 2026-08-14.
The 52-week high and low of Curis Lifesciences Ltd. are ₹147.90 and ₹83.60, respectively, as of 2026-08-14.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
